1. Home
  2. ADPT vs IBCP Comparison

ADPT vs IBCP Comparison

Compare ADPT & IBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADPT
  • IBCP
  • Stock Information
  • Founded
  • ADPT 2009
  • IBCP 1864
  • Country
  • ADPT United States
  • IBCP United States
  • Employees
  • ADPT N/A
  • IBCP N/A
  • Industry
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • IBCP Major Banks
  • Sector
  • ADPT Health Care
  • IBCP Finance
  • Exchange
  • ADPT Nasdaq
  • IBCP Nasdaq
  • Market Cap
  • ADPT 929.8M
  • IBCP 791.0M
  • IPO Year
  • ADPT 2019
  • IBCP N/A
  • Fundamental
  • Price
  • ADPT $5.94
  • IBCP $36.00
  • Analyst Decision
  • ADPT Buy
  • IBCP Hold
  • Analyst Count
  • ADPT 4
  • IBCP 3
  • Target Price
  • ADPT $6.75
  • IBCP $34.83
  • AVG Volume (30 Days)
  • ADPT 1.4M
  • IBCP 66.5K
  • Earning Date
  • ADPT 02-12-2025
  • IBCP 01-23-2025
  • Dividend Yield
  • ADPT N/A
  • IBCP 2.54%
  • EPS Growth
  • ADPT N/A
  • IBCP 3.52
  • EPS
  • ADPT N/A
  • IBCP 2.94
  • Revenue
  • ADPT $177,282,000.00
  • IBCP $208,212,000.00
  • Revenue This Year
  • ADPT $6.48
  • IBCP N/A
  • Revenue Next Year
  • ADPT $18.84
  • IBCP $5.96
  • P/E Ratio
  • ADPT N/A
  • IBCP $12.85
  • Revenue Growth
  • ADPT N/A
  • IBCP 3.25
  • 52 Week Low
  • ADPT $2.28
  • IBCP $22.53
  • 52 Week High
  • ADPT $7.07
  • IBCP $40.32
  • Technical
  • Relative Strength Index (RSI)
  • ADPT 61.49
  • IBCP 53.83
  • Support Level
  • ADPT $5.98
  • IBCP $36.95
  • Resistance Level
  • ADPT $6.93
  • IBCP $38.30
  • Average True Range (ATR)
  • ADPT 0.45
  • IBCP 0.95
  • MACD
  • ADPT 0.03
  • IBCP -0.18
  • Stochastic Oscillator
  • ADPT 75.53
  • IBCP 47.89

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About IBCP Independent Bank Corporation

Independent Bank Corp (Ionia MI) operates as a commercial bank. It offers a broad range of banking services to individuals and businesses, including checking and savings accounts, commercial lending, direct and indirect consumer financing, mortgage lending, and safe deposit box services. It also provides internet and mobile banking capabilities to its customers.

Share on Social Networks: